Consensus InspireMD, Inc.

Equities

NSPR

US45779A8466

Market Closed - Nasdaq Other stock markets 02:00:01 15/05/2024 am IST			5-day change	1st Jan Change
2.382 ^USD	-0.75%		+12.36%	-15.23%

14/05	Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024
14/05	Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M	MT

Evolution of the average Target Price on InspireMD, Inc.

Price target over the last 5 years

History of analyst recommendation changes

19115e8b9bff2611.71AdiJ4xKdIkSFQFTPOABjxHdRzY8weYctov5vuorxI.oyF36_t6cbF-Eg5WCov1Nls2TFWeh2HvH-J8sp3x-SS4MVjC2kgQ5khwZA~02fc8ada9796c9de937375b989f863d3

Analyst Recommendations on InspireMD, Inc.

Piper Sandler Initiates InspireMD at Overweight With $3 Price Target	12/23/12	MT
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating	17/23/17	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.382 USD

Average target price

4.5 USD

Spread / Average Target

+88.92%

High Price Target

4.5 USD

Spread / Highest target

+88.92%

Low Price Target

4.5 USD

Spread / Lowest Target

+88.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering InspireMD, Inc.

Piper Sandler
Alliance Global Partners

Quarterly earnings - Rate of surprise

Company calendar